4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-24-000592
SVP AND CFO acquired 10,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martin Samuel Bates SVP AND CFO | 2024-01-02 | Option exercise | +10,750 | $2.78 | $29,885 | 35,128 | D |
| Derivatives | |||||||
| Martin Samuel Bates SVP AND CFO | 2024-01-02 | Option exercise · Incentive Stock Option (Right to Buy) | −10,750 | 0 | D | ||
Loading xslF345X05/form4-01042024_090138.xml…